The state-of-the-art facility will produce high-precision and complex medical device components
12 June 2024
Theragenics, the parent company of Sligo-based Arrotek Medical, has started work on a new $10 million medical device manufacturing facility in Costa Rica. The new manufacturing plant will enhance the capabilities and capacity of Arrotek as the company further expands its global operations.
Arrotek specialises in the design of innovative minimally invasive medical devices, including cutting-edge catheter technologies as well as guidewires, needles, and more. Its purpose-built facility in Finisklin, Sligo has extensive design, regulatory, and manufacturing capabilities with an expanding team of more than 100 employees.
Arrotek’s Irish manufacturing capabilities focus mostly on polymer-based components with its new facility in Costa Rica enabling it to scale its production services due to increasing demand from its customer base.
State-of-the-Art Equipment and Technologies
Construction of the new 5,500-square-metre facility in Costa Rica started in April 2024. The plant, which includes 2,000 square meters of production floor and a 1,000 square meter cleanroom built to Class 8 standards, is expected to be fully operational by Q2, 2025.
The new facility will feature state-of-the-art equipment and technologies. It will have the capabilities and capacity to produce high-precision and often complex components for leading medical device products.
Sligo native Mark Pugh co-founded Arrotek. He was appointed CEO of the Theragenics Corporation in January 2024, so he now leads the global group of companies that includes Theragenics, Arrotek, and Galt Medical.
Commenting on the investment, Mark said: “This is an exciting time for Theragenics as we continue to expand our operations.
“High precision specialty medical needles are crucial components for many minimally invasive medical devices. In fact, needles are becoming even more important as medical device products get smaller and more complex.
“This makes needles a rapidly growing market in the medical device industry. The new Theragenics facility that we are building in Costa Rica will be at the forefront of global needle production and supply.
“At Theragenics, we have a strong track record and industry reputation for designing and manufacturing high-quality minimally invasive medical device components and products for a wide range of customers, from the world’s largest life sciences organisations to OEMs to customers in the healthcare sector.
“We are also an ambitious and innovative company that continuously pushes boundaries, developing solutions that exceed the expectations of our customers. Our new Costa Rica manufacturing facility is central to our growth strategy, and I am looking forward to working with the growing team.”
Ends.
About Arrotek
Arrotek is a medical device design consultancy headquartered in Finisklin, Sligo, Ireland. It also has a consultancy and manufacturing facility in Massachusetts, USA, and work is ongoing on a new manufacturing plant in Costa Rica. Arrotek offers a comprehensive range of medical device design, development, and manufacturing services with a focus on minimally invasive medical devices, including interventional and diagnostic catheters as well as guidewires, needles, stylets, cannulas, and similar components.
About Theragenics
Theragenics (www.theragenics.com) is a leader in cutting-edge medical solutions, offering minimally invasive medical devices and radiation-based treatments that improve patient outcomes. Through our subsidiaries Arrotek (www.arrotek.com) and Galt (www.galtmedical.com), we design and deliver a broad range of vascular access devices, needles, catheters, guidewires, and more. We also partner with global medical device companies to provide comprehensive design, manufacturing, and regulatory support services.
